TRACE: Tirapazamine-Radiation And Cisplatin Evaluation

PHASE3CompletedINTERVENTIONAL
Enrollment

317

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

Tirapazamine

in combination with cisplatin and concomitant radiation

DRUG

Cisplatin

with concomitant radiation

Trial Locations (17)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Cove

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Causeway Bay

Sanofi-Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Milan

sanofi-aventis New Zealand administrative office, Macquarie Park

Sanofi-Aventis Administrative Office, Warsaw

Sanofi-Aventis Administrative Office, Singapore

Sanofi-Aventis Administrative Office, Midrand

Sanofi-Aventis Administrative Office, Barcelona

Sanofi-Aventis Administrative Office, Geneva

Sanofi-Aventis Administrative Office, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Groupe Oncologie Radiotherapie Tete et Cou

OTHER

lead

Sanofi

INDUSTRY